doi: 10.1016/j.ejphar.2017.06.029 112
For most individuals, this sensation is mild and subsides significantly within the first week or two as the body adapts to the medication
Baekdal TA, Thomsen M, Kupov V, Hansen CW, Anderson TW
Studies have found that L-carnitine supplementation can raise levels of another compound, TMAO, which has been associated with higher levels of cardiovascular disease, this even though most studies have found that carnitine is good for the heart
Because Medicare patients often face overlapping risks such as chronic kidney disease and cardiovascular complications, multi-indication agents such as the SGLT2s remain an important complementary option alongside GLP1s
Microbiome + SCFAs: The Foundation for Natural GLP-1 Signalling The gut microbiome ferments fiber into short-chain fatty acids (SCFAs) butyrate, propionate, acetate